Albireo Pharma, Inc.
Albireo Pharma, Inc. (ALBO) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ALBO · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
52
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Albireo Pharma, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ALBO insider buying and selling by quarter
ALBO insider selling · ALBO insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Recent insider transactions
ALBO executive sell shares · ALBO board member insider trading · ALBO insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 2, 2023 | Chiswell David Director | Other | 56,278 | $563K | Form 4 |
| Mar 2, 2023 | Harford Simon N.R. CFO and Treasurer | Other | 13,739 | $137K | Form 4 |
| Mar 2, 2023 | Cooper Ronald Harold Wilfred President and CEO · Director | Other | 33,094 | $331K | Form 4 |
| Mar 2, 2023 | Stephenson Pamela Chief Commercial Officer | Other | 22,242 | $222K | Form 4 |
| Mar 2, 2023 | Graham Michelle Chief Human Resources Officer | Other | 5,543 | $55K | Form 4 |
| Mar 2, 2023 | Carter Martha J. Chief Regulatory Officer | Other | 3,656 | $37K | Form 4 |
| Mar 2, 2023 | Duncan Jason Chief Legal Officer and GC | Other | 3,296 | $33K | Form 4 |
| Mar 2, 2023 | Mattsson Jan Chief Scientific Officer | Other | 35,524 | $355K | Form 4 |
| Jan 19, 2023 | Cooper Ronald Harold Wilfred President and CEO | Award | 195,000 | — | Form 4 |
| Jan 19, 2023 | Mattsson Jan Chief Scientific Officer | Award | 55,000 | — | Form 4 |
| Jan 19, 2023 | Duncan Jason Chief Legal Officer and GC | Award | 55,000 | — | Form 4 |
| Jan 19, 2023 | STRECK PAUL Chief Medical Officer | Award | 55,000 | — | Form 4 |
| Jan 23, 2023 | Stephenson Pamela Chief Commercial Officer | Sale | 102 | $4K | Form 4 |
| Jan 23, 2023 | Graham Michelle Chief Human Resources Officer | Sale | 102 | $4K | Form 4 |
| Jan 23, 2023 | Mattsson Jan Chief Scientific Officer | Sale | 197 | $9K | Form 4 |
| Jan 23, 2023 | Harford Simon N.R. CFO and Treasurer | Sale | 102 | $4K | Form 4 |
| Jan 23, 2023 | Duncan Jason Chief Legal Officer and GC | Sale | 228 | $10K | Form 4 |
| Jan 23, 2023 | Cooper Ronald Harold Wilfred President and CEO | Sale | 1,057 | $46K | Form 4 |
| Jan 23, 2023 | Carter Martha J. Chief Regulatory Officer | Sale | 120 | $5K | Form 4 |
Harford Simon N.R.
CFO and Treasurer
Date
Mar 2
Shares
13,739
Price
$10.00
Value
$137K
Cooper Ronald Harold Wilfred
President and CEO · Director
Date
Mar 2
Shares
33,094
Price
$10.00
Value
$331K
Stephenson Pamela
Chief Commercial Officer
Date
Mar 2
Shares
22,242
Price
$10.00
Value
$222K
Graham Michelle
Chief Human Resources Officer
Date
Mar 2
Shares
5,543
Price
$10.00
Value
$55K
Carter Martha J.
Chief Regulatory Officer
Date
Mar 2
Shares
3,656
Price
$10.00
Value
$37K
Duncan Jason
Chief Legal Officer and GC
Date
Mar 2
Shares
3,296
Price
$10.00
Value
$33K
Mattsson Jan
Chief Scientific Officer
Date
Mar 2
Shares
35,524
Price
$10.00
Value
$355K
Cooper Ronald Harold Wilfred
President and CEO
Date
Jan 19
Shares
195,000
Price
—
Value
—
Stephenson Pamela
Chief Commercial Officer
Date
Jan 23
Shares
102
Price
$43.80
Value
$4K
Graham Michelle
Chief Human Resources Officer
Date
Jan 23
Shares
102
Price
$43.80
Value
$4K
Mattsson Jan
Chief Scientific Officer
Date
Jan 23
Shares
197
Price
$43.80
Value
$9K
Duncan Jason
Chief Legal Officer and GC
Date
Jan 23
Shares
228
Price
$43.80
Value
$10K
Cooper Ronald Harold Wilfred
President and CEO
Date
Jan 23
Shares
1,057
Price
$43.80
Value
$46K
Carter Martha J.
Chief Regulatory Officer
Date
Jan 23
Shares
120
Price
$43.80
Value
$5K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ALBO insider trading
ALBO insider trades
Albireo Pharma, Inc. (ALBO) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ALBO. Over the past 12 months, 0 insiders have filed transactions with the SEC. ALBO insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Albireo Pharma, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ALBO insider trading · 5 questionsThe insiders of Albireo Pharma, Inc. (ALBO) include executives and directors such as ALBO, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026